Myotonic dystrophies 1 and 2: Complex diseases with complex mechanisms

Current Genomics

Volumn 11, Issue 2, 2010, Pages 77-90

  Schoser, Benedikt ^a   Timchenko, Lubov ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN CUGBP1; PROTEIN MBNL1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

CLINICAL FEATURE; HUMAN; MOLECULAR GENETICS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; PROTEIN METABOLISM; REVIEW; RNA PROCESSING;

EID: 77950434868     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210790886844     Document Type: Review

References (102)

1. Batten, F.E.; Gibb H.P. Myotonia atrophica. Brain 1909, 32, 187-205.
2. Steinert, H. Myopathologische Beiträge 1. Über das klinische und anatomische Bild des Muskelschwunds der Myotoniker. Dtsch. Zeitschr. Nervenheilk. 1909, 37, 58-104.
3. Curschmann, H. Über familiäre atrophische Myotonie. Dtsch. Zeitschr Nervenheilk. 1912, 45, 161-202.
4. rd ed.; W.B. Saunders: Philadelphia; 2001.
5. Fleischer, B. Über myotonische Dystrophie mit Katarakt. Graefes. Arch. Klein. Ophthalmol., 1918, 96, 91-133.
6. Ricker, K.; Koch, M.C.; Lehmann-Horn, F.; Pongratz, D.; Otto, M.; Heine, R.; Moxley, R.T. 3rd. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology, 1994, 44, 1448-1452.
7. Thornton, C.A.; Griggs, R.C.; Moxley, III R.T. Myotonic dystrophy with no trinucleotide repeat expansion, Ann. Neurol., 1994, 35, 269-272.
8. Liquori, C.L.; Ricker, K.; Moseley, M.L.; Jacobsen, J.F.; Kress, W.; Naylor, S.L.; Day, J.W.; Ranum, L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 2001, 293, 864-867.
9. Udd, B.; Meola, G.; Krahe, R.; Thornton, C.A.; Ranum, L.P.; Day, J.W.; Bassez, G.; Ricker, K. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies: 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscl. Disord., 2003, 13, 589-596.
10. Vanier, T.M. Dystrophia myotonica in childhood. Br. Med. J., 1960, 2, 1284-1288.
11. Schara, U., Schoser B.G.H. Myotonic Dystrophies type 1 and 2 - a summary of current aspects. Semi. Pediatr. Neurol., 2006, 13, 71-79.
12. Day, J.W.; Ricker, K.; Jacobson, J.F.; Rasmussen, L.J.; Dick, K.A.; Kress, W.; Schneider, C.; Koch, M.C.; Beilman, G.J.; Harrison, A.R.; Dalton, J.C.; Ranum, L.P. Myotonic dystrophy type 2. Neurology, 2003, 60, 657-664.
13. Schoser, B.; Ricker, K.; Schneider-Gold, C.; Hengstenberg, C.; Dürre, J.; Bültmann, B.; Kress, W.; Day, J.W.; Ranum, L.P. Sudden death in myotonic dystrophy type 2. Neurology, 2004, 63, 966-967.
14. Maurage, C.A.; Udd, B.; Ruchoux, M.M.; Vermersch, P.; Kalimo, H.; Krahe, R.; Delacourte, A.; Sergeant, N. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease, Neurology, 2005, 65, 1636-1638.
15. Machuca-Tzili, L.; Brook, D.; Hilton-Jones, D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve, 2005, 32, 1-18.
16. Schoser, B.; Schneider-Gold, C.; Kress, W.; Goebel, H.H.; Reilich, P.; Koch, M.C.; Pongratz, D.E.; Toyka, K.V.; Lochmüller, H.; Ricker K. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve, 2004, 29, 275-281.
17. Harley, H.G.; Brook, J.D.; Rundle, S.A.; Crow, S.; Reardon, W.; Buckler, A.J.; Harper, P.S.; Housman, D.E.; Shaw, D.J. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature, 1992, 355, 545-546.
18. Buxton, J.; Shelbourne, P.; Davies, J.; Jones, C.; Van Tongeren, T.; Aslanidis, C.; de Jong, P.; Jansen, G.; Anvret, M.; Riley, B.; Williamson, R.; Johnson, K. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature, 1992, 355, 547-548.
19. Ranum, L.P.; Rasmussen, P.F.; Benzow, K.A.; Koob, M.D.; Day, J.W. Genetic mapping of a second myotonic dystrophy locus. Nat. Genet., 1998, 19, 196-198.
20. Day, J.W.; Ranum, L.P. RNA pathogenesis of the myotonic dystrophies, Neuromuscul. Disord., 2005, 15, 5-16.
21. Liquori, C.L.; Ikeda, Y.; Weatherspoon, M.; Ricker, K.; Schoser, B.G.; Dalton, J.C.; Day, J.W.; Ranum, L.P. Myotonic Dystrophy Type 2: Human founder haplotype and evolutionary conservation of the repeat tract. Am. J. Hum. Genet., 2003, 73, 849-862.
22. Bachinski, L.L.; Udd, B.; Meola, G.; Sansone, V.; Bassez, G.; Eymard, B.; Thornton, C.A.; Moxley, R.T.; Harper, P.S.; Rogers, M.T.; Jurkat-Rott, K.; Lehmann-Horn, F.; Wieser, T.; Gamez, J.; Navarro, C.; Bottani, A.; Kohler, A.; Shriver, M.D.; Sallinen, R.; Wessman, M.; Zhang, S.; Wright, F.A.; Krahe, R. Confirmation of DM2 (CCTG)n expansion mutation in PROMM/PDM patients of different European origins: a single shared haplotype indicates ancestral founder effects. Am. J. Hum. Genet., 2003, 73, 835-848.
23. Schoser, B.; Kress, W.; Walter, M.C.; Halliger-Keller, B.; Lochmüller, H.; Ricker K. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain, 2004, 127, 1868-1877.
24. Lamusi, B.; Artero, R. Molecular effects of the CTG repeats in mutant dystrophia myotonica protein kinase gene. Curr. Genomics, 2008, 9, 509-516.
25. Wang, J.; Pegoraro, E.; Menegazzo, E.; Gennarelli, M.; Hoop, R.C.; Angelini, C.; Hoffman, E.P. Myotonic Dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet., 1995, 4, 599-606.
26. Taneja, K.L.; McCurrach, M.; Schalling, M.; Housman, D.; Singer, R.H. Foci of trinucleotide repeat transcripts in nuclei of Myotonic Dystrophy cells and tissues. J. Cell Biol., 1995, 128, 995-1002.
27. Timchenko, L.T.; Timchenko, N.A.; Caskey, C.T.; Roberts, R. Novel proteins with binding specificity to DNA CTG and RNA CUG repeats: implications for myotonic dystrophy. Hum. Mol. Genet., 1996, 5, 115-121.
28. Timchenko, L.T.; Miller, J.W.; Timchenko, N.A.; DeVore, D. R.; Datar, K.V.; Lin, L.; Roberts, R.; Caskey, C.T.; Swanson, M.S. Identification of a (CUG)n triplet repeat binding protein and its expression in myotonic dystrophy. Nucleic Acids Res., 1996, 24, 4407-4414.
29. Caskey, C.T.; Swanson, M.S.; Timchenko, L.T.. Myotonic dystrophy: discussion of molecular mechanism. Cold Spring Harbor Symposia on Quantitative Biology "Function and dysfunction in the nervous system" 1996, 61, pp. 607-614.
30. Timchenko, L.T. Myotonic dystrophy: the role of RNA CUG repeats. Am. J. Hum. Genet., 1999, 64, 360-364.
31. Miller, J.W.; Urbinati, C. R.; Teng-Umnuay, P.; Stenberg, M.G.; Byrne, B. J.; Thornton, C. A.; Swanson, M.S. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J., 2000, 19, 4439-4448.
32. Mankodi, M.; Logigian, E.; Callahan, L.; McClain, C.; White, R.; Henderson, D.; Krym, M.; Thornton, C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science, 2000, 289, 1769-1772.
33. Seznec, H.; Agbulut, O.; Sergeant, N.; Savouret, C.; Ghestem, A.; Tabti, N.; Willer, J. C.; Ourth, L.; Duros, E.; Brisson, E.; Fouquet, C.; Butler-Browne, G.; Delacourte, A.; Junien, C.; Gourdon, G. Mice transgenic for the human myotonic dystrophy with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet., 2001, 10, 2717-2726.
34. Mahadevan, M.S.; Yadava, R.S.; Yu, Q.; Balijepalli, S.; Frenzel-McCardell, C.D.; Bourne, T.D.; Phillips, L.H. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat. Genet., 2006, 38, 1066-1070.
35. Timchenko, L.; Monckton, D.; Caskey, C.T. Myotonic dystrophy: an unstable CTG repeat in a protein kinase gene. Sem. Cell Biol., 1995, 6, 13-19.
36. Krahe, R.; Ashizawa, T.; Abbruzzese, C.; Roeder, E.; Carango, P.; Giacanelli, M.; Funanage, V.L.; Siciliano, M.J. Effect of Myotonic Dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics, 1995, 28, 1-14.
37. Davis, B.M.; McCarrach, M.E.; Taneja, K.L.; Singer, R.H.; Housman, D.E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA, 1997, 94, 7388-7393.
38. Hamshere, M.G.; Newman, E.E.; Alwazzan, M.; Athwal, B.S.; Brook, J.D. Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc. Natl. Acad. Sci. USA, 1997, 94, 7394-7399.
39. Timchenko, N.A.; Cai, Z-J.; Welm, A.L.; Reddy, S.; Ashizawa, T.; Timchenko, L.T. RNA CUG repeats sequester and alter protein levels and activity of CUGBP1. J. Biol. Chem., 2001, 276, 7820-7826.
40. Ebralidze, A.; Wang, Y.; Petkova, V.; Ebralidze, K.; Junghans, R. P. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science, 2004, 303, 383-387.
41. Junghans, R.P. Dystrophia myotonia: why focus on foci? Eur. J. Hum. Genet., 2009, 17, 543-553.
42. Jensen, T.H.; Patricio, K.; McCarthy, T.; Rosbash, M. A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription. Mol. Cell, 2001, 7, 887-898.
43. Hilleren, P.; McCarthy, T.; Rosbash, M.; Parker, R.; Jensen, T.H. Quality control of mRNA 3′-end processing is linked to the nuclear exosome. Nature, 2001, 413, 538-542.
44. Ho, H.T.H.; Savcur, R.S.; Poulos, M.G.; Mancini, M.A.; Swanson, M.S.; Cooper, T.A. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell Sci., 2005, 118, 2923-2933.
45. Smith, K.P.; Byron, M.; Xing, Y.; Lawrence, J.B. Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type 1 is blocked at entry into SC-35 domains. J. Cell Biol., 2007, 1768, 951-964.
46. Holt, I.; Mittal, S.; Furling, D.; Butler-Browne, G.S.; Brook, J.D.; Morris, G.E. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells, 2007, 12, 1035-1048.
47. Dansingthong, W.; Wolf, C.M.; Sarkar, P.; Paul, S.; Chiang, A.; Holt, I.; Morris, G.E.; Branco, D.; Sherwood, M.C.; Comai, L.; Berul, C.I.; Reddy, S. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. PLoS ONE, 2008, 3, 1-18.
48. Varallayay, E.; Burgyan, J.; Havelada, Z. MicroRNA detection by northern blotting using locked nucleic acid probes. Nat. Protoc., 2008, 3, 190-196.
49. Flink, I.L.; Morkin, E. Alternatively processed isoforms of cellular nucleic acid-binding protein interact with a suppressor region of the human beta-myosin heavy chain gene. J. Biol. Chem., 1995, 270, 6959-6965.
50. Margolis, J.M.; Schoser, B.G.; Moseley, M.L.; Day, J.W.; Ranum L.P.W. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum. Mol. Genet., 2006, 15, 1808-1815.
51. Botta, A.; Caldarola, S.; Vallo, L.; Bonifazi, E.; Fruci, D.; Gullotta, F.; Massa, R.; Novelli, G.; Loreni, F. Effect of the[CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy II (DM2). Biochem. Biophys. Acta, 2006, 1762, 329-334.
52. Salisbury, E.; Schoser, B.; Schneider-Gold, C.; Wang, G-L.; Huichalaf, C.; Jin, B.; Sirito, M.; Sarkar, P.; Krahe, R.; Timchenko, N.A.; Timchenko, L.T. Expression of RNA CCUG Repeats Dysregulates Translation and Degradation of Proteins in Myotonic Dystrophy 2 Patients. Am. J. Pathol., 2009, 175, 748-762.
53. Clement, J.Q.; Maiti, S.; Wilkinson, M.F. Localization and stability of introns spliced from the Pem homeobox gene. J. Biol. Chem., 2001, 20, 16919-16930.
54. Mankodi, A.; Urbinati, C.R.; Yuan, Q.P.; Moxley, R.T.; Sansone, V.; Krym, M.; Henderson, D.; Schalling, M.; Swanson, M.S.; Thornton, C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet., 2001, 10, 2165-2170.
55. Kanadia, R. N.; Johnstone, K. A.; Mankodi, A.; Lungu, C.; Thornton, C. A.; Esson, D.; Timmers, A. M.; Hauswirth, W. W.; Swanson. M. S. 2003. A muscleblind knockout model for myotonic dystrophy. Science, 2003, 302, 1978-1980.
56. Kanadia, R.N.; Shin, J.; Yuan, Y.; Beattie, S.G.; Wheeler, T.M.; Thornton, C.A.; Swanson, M.S. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. USA, 2006, 103, 11748-11753.
57. de Haro, M.; Al-Ramahi, I.; De Gouyon, B.; Ukani, L.; Rosa, A.; Faustino, N.A.; Ashizawa, T.; Cooper, T.A.; Botas, J. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of Myotonic Dystrophy 1. Hum. Mol. Genet., 2006, 15, 2138-2145.
58. Michalowski, S.; Miller, J.W.; Urbitani, C.R.; Paliouras, M.; Swanson, M.S.; Griffith, J. Visulaization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res., 1999, 27, 3534-3542.
59. Houseley, J.M.; Wang, Z.; Brock, G.J.R.; Soloway, J.; Artero, R.; Perez-Alonso, M.; O'Dell, K.M.C.; Monckton, D.G. Myotonic Dystrophy associated CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Hum. Mol. Genet., 2005, 14, 873-883.
60. Le Mee, G.; Ezzeddine, N.; Capri, M.; Ait-Ahmed, O. Repeats length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models. PLoS ONE, 2008, 3, 1-10.
61. Garcia-Lopez, A.; Monferrer, L.; Gracia-Alcover, I.; Vicentew-Crespo, M.; Alvarez-Abril, M.C.; Artero, R.D. Genetic and chemical modifiers of a CUG toxicity model in Drosophila. PLoS ONE, 2008, 3, 1-10.
62. Savcur, R.S.; Philips, A.V.; Cooper, T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 2001, 29, 40-47.
63. Kuyumcu-Martinez, N. M.; Wang, G-S.; Cooper, T. A. 2007. Increased steady-state levels of CUGBP1 in myotonic dystrophy are due to PKC-mediated hyperphosphorylation. Mol. Cell, 2007, 28, 68-78.
64. Wang, G-S.; Kearney, D.L.; Biasi, M. D.; Taffet, G.; Cooper, T.A. Elevation of RNA-binding protein, CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J. Clin. Invest., 2007, 117, 2802-2811.
65. Orengo, J.P.; Chambon, P.; Metzger, D.; Mosier, D.S.; Snipes, G.J.; Cooper, T.A. Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc. Natl. Acad. Sci. USA, 2008, 105, 2646-2651.
66. Lin, X.; Miller, J.W.; Mankodi, A.; Kanadia, R.N.; Yuan, Y.; Moxley, R.T.; Swanson, M.S.; Thornton, C.A. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 2006, 15, 2087-2097.
67. Pelletier, R.; Hamel, F.; Beaulieu, D.; Patry, L.; Haineault, C.; Tarnopolsky, M.; Schoser, B.; Puymirat, J. Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol. Dis., 2009, 36, 181-190.
68. Ho, T.H.; Bundman, D.; Amstrong, D.L.; Cooper, T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet., 2005, 14, 1539-1547.
69. Philips, A.V.; Timchenko, L.T.; Cooper, T.A. Disruption of splicing of regulated by CUG binding protein in myotonic dystrophy. Science, 1999, 280, 737-741.
70. Charlet-B, N.; Savcur, R. S.; Singh, G.; Philips, A. V.; Grice, E. A.; Cooper, T.A. Loss of the Muscle specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell, 2002, 10, 45-143
71. Timchenko, N.A.; Welm, A.L.; Lu, X.; Timchenko, L.T. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBP beta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res., 1999, 27, 4517-4525.
72. Timchenko, N.A.; Iakova, P.; Cai, Z-J.; Smith, J.R.; Timchenko, L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol., 2001, 21, 6927-6938.
73. Timchenko, N.A.; Patel, R.; Iakova, P.; Cai, Z.-J.; Quan, L.; Timchenko, L. T. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem., 2004, 279, 13129-13139.
74. Iakova, P.; Wang, G-L.; Timchenko, L.T.; Michalak, M.; Pereira-Smith, O.M.; Smith, J.R.; Timchenko, N.A. 2004. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J., 2004, 23, 406-417.
75. Timchenko, N.A.; Wang, G-L.; Timchenko, L.T. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/Enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. J. Biol. Chem., 2005, 280, 20549-20557.
76. Timchenko, L.T.; Salisbury, E.; Wang, G.-L.; Nguyen, H.; Albrecht, J.H.; Hershey, J.W.B.; Timchenko, N.A. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/Enhancer-binding protein beta in old liver. J. Biol. Chem., 2006, 281, 32806-32819.
77. Woeller, C. F.; Fox, J. T.; Perry, C.; Stover, P. J. A ferritin-responsive ribosome entry site regulates folate metabolism. J. Biol. Chem., 2007, 282, 29927-29935.
78. Salisbury, E.; Sakai, K.; Schoser, B.; Huichalaf, C.; Schneider-Gold, C.; Nguen, H.; Wang, G-L.; Albrecht, J. H.; Timchenko, L.T. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. Exp. Cell Res., 2008, 314, 2266-2278.
79. Paillard, L.; Omilli, F.; Legagneux, V.; Bassez, T.; Maniey, D.; Osborne, H.B. EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus Laevis. EMBO J., 1998, 17, 278-287.
80. Moraes, K.C.M.; Wilusz, C. J.; Wilusz, J. CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA, 2006, 12, 1084-1091.
81. Barreau, C. B.; Paillard, L.; Mereau, A.; Osborne, H.B. 2006. Mammalian CELF/Bruno-like RNA binding proteins: molecular characteristics and biological functions. Biochimie, 2006, 88, 515-525.
82. Webster, P.J.; Liang, L.; Berg, C.A.; Lasko, P.; Macdonald, P. M. Translational repressor bruno plays multiple roles in development and is widely conserved. Genes Dev., 1997, 11, 2510-2521.
83. Vlasova, I.A.; Tahoe, N.M.; Fan, D.; Larrson, O.; Rattenbacher, B.; SternJohn, J.R.; Vasdewani, J. M.; Karypis, G.; Reilly, C.S.; Bitterman, P.B.; Bohjanen, P.R. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol. Cell, 2008, 29, 263-270.
84. Kim, H. H.; Gorospe, M. GU-rich RNA: Expanding CUGBP1 function, broadening mRNA turnover. Mol. Cell, 2008, 29, 151-152.
85. Ranum, L.W.; Day, J.W. Myotonic Dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet., 2004, 74, 793-804.
86. Roberts, R.; Timchenko, N.A.; Miller, J.W.; Reddy, S.; Caskey, C.T.; Swanson, M. S.; Timchenko, L. T. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA, 1997, 94, 13221-13226.
87. Zhang, L.; Lee, J.E.; Wilusz, J.; Wilusz, C.J. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells. J. Biol. Chem., 2008, 283, 22457-22463.
88. Mammarella, A.; Ferroni, P.; Paradiso, M.; Martini, F.; Paoletti, V.; Morino, S.; Antonini, G.; Gazzaniga, P. P.; Musca, A.; Basili, S. Tumor necrosis factor-alpha and myocardial function in patients with myotonic dystrophy 1. J. Neurol. Sci., 2002, 201, 59-64.
89. Kress, C.; Gautier-Courteille, C.; Osborne, H.B.; Babinet, C.; Paillard, L. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol. Cell. Biol., 2007, 27, 1146-1157.
90. Osborne, R.J.; Lin, X.; Welle, S.; Sobczak, K.; O'Rourke, J.R.; Swanson, M.S.; Thornton, C.A. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet., 2009, 18, 1471-1481.
91. Wang, G-L.; Salisbury, E.; Shi, X.; Timchenko, L.; Medrano, E.E.; Timchenko, N.A. HDAC1 promotes liver proliferation in young mice via interactions with C/EBPbeta. J. Biol. Chem., 2008, 283, 26179-26187.
92. Yuan, Y.; Compton, S.A.; Sobczak, K.; Stenberg, M.G.; Thornton, C.A.; Griffith, J.D.; Swanson, M.S. Muscle blind-like 1 interacts with RNA hairpins in splicing targets and pathogenic RNAs. Nucleic Acids Res., 2007, 35, 5474-5486.
93. Warf, M.B.; Berglund, J.A. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA, 2007, 13, 2238-2251.
94. Mooers, B. H.; Logue, J. S.; Berglund, J. A. The structural basis of myotonic dystrophy from the crystal structure of CUG repeats. Proc. Natl. Acad. Sci. USA, 2005, 102, 16626-16631.
95. Chen, W.; Wang, Y.; Abe, Y.; Cheney, L.; Udd, B.; Li, Y. P. Haploinsufficiency for Znf9 in Znf9+/-mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J. Mol. Biol., 2007, 368, 8-17.
96. Huichalaf, C.; Schoser, B.; Schneider-Gold, C.; Jin, B.; Sarkar, P.; Timchenko, L. Reduction of the rate of protein translation in patients with myotonic dystrophy 2. J. Neurosci., 2009, 29, 9042-9049.
97. Pellizzoni, L.; Lotti, F.; Maras, B.; Pierandrei-Amaldi, P. Cellular nucleic acid binding protein binds a conserved region of the 5′ UTR of Xenopus laevis ribosomal protein mRNAs. J. Mol. Biol., 1997, 267, 264-275.
98. Gerbasi, V.R.; Link, A.J. The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Mol. Cell. Proteomics, 2007, 6, 1049-1058.
99. Krol, J.; Fiszer, A.; Mykowska, A.; Sobczak, K.; de Mezer, M.; Krzyzosiak, W.J. Ribonuclease Dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol. Cell, 2007, 25, 575-586.
100. Storbeck, C. J.; Drmanic, S.; Daniel, K.; Waring, J.D.; Jirik, F.R.; Parry, D.J.; Ahmed, N.; Sabourin, L.A.; Ikeda, J-E.; Korneluk, R.G. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3′ UTR. Hum. Mol. Genet., 2004, 13, 589-600.
101. Langlois, M.-A.; Boniface, C.; Wang, G.; Alluin, J.; Salvaterra, P.M.; Puymirat, J.; Rossie, J. J.; Lee, N.S. Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in Myotonic Dystrophy cells. J. Biol. Chem., 2005, 280, 16949-16954.
102. Wheller, T.M.; Sobczak, K.; Lueck, J.D.; Osborne, R.J.; Lin, X.; Dirksen, R.T.; Thornton, C.A. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science, 2009, 325, 336-339.